Buscar resultados de ensayos clínicos
Hemorrhagic Fever - 110 Studies Found
Estado | Estudiar |
Enrolling by invitation |
Nombre del estudio: Ribavirin for Hemorrhagic Fever With Renal Syndrome Condición: Hemorrhagic Fever With Renal Syndrome Fecha: 2008-02-13 Intervenciones: Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day |
Enrolling by invitation |
Nombre del estudio: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever Condición: Viral Hemorrhagic Fever Fecha: 2015-06-24 Intervenciones: Drug: Ribavirin |
Active, not recruiting |
Nombre del estudio: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans Condición: Crimean-Congo Hemorrhagic Fever Fecha: 2017-01-11 Intervenciones:
|
Withdrawn |
Nombre del estudio: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany Condición: Hemorrhagic Fever With Renal Syndrome Fecha: 2009-03-24 Intervenciones: Drug: Virazole (Ribavirin) Duration of Subject Participati |
Active, not recruiting |
Nombre del estudio: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Condición: Hemorrhagic Fever With Renal Syndrome Fecha: 2014-04-14 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities Condición:
Fecha: 2009-10-08 Intervenciones: Drug: Ribavirin (Virazole) Injection The drug is to be adm |
Completed |
Nombre del estudio: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Condición: Hemorrhagic Fever With Renal Syndrome Fecha: 2011-12-23 Intervenciones: Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio |
Active, not recruiting |
Nombre del estudio: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda Condición: Hemorrhagic Fever, Ebola Fecha: 2015-01-29 Intervenciones:
|
Recruiting |
Nombre del estudio: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi Condición: Ebola Hemorrhagic Fever Fecha: 2016-09-14 Intervenciones: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Recruiting |
Nombre del estudio: Open Study of the Duration of Immunity After Vaccination With GamEvac Condición: Hemorrhagic Fever, Ebola Fecha: 2016-09-14 Intervenciones: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |